-+ 0.00%
-+ 0.00%
-+ 0.00%

Tango Therapeutics President, R&D Adam Crystal Reports Sale of $125,000 in Common Shares

PUBT·11/13/2026 23:41:05
Tango Therapeutics President, R&D Adam Crystal Reports Sale of $125,000 in Common Shares
  • Tango Therapeutics President, R&D Adam Crystal sold 5,000 shares of common stock at $25 each on Nov. 11, 2026.
  • Crystal exercised stock options for 5,000 shares at $2.91 per share on the same date.
  • Following the transactions, he directly held 115,743 shares of common stock and 308,090 stock options.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tango Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-461212), on November 13, 2026, and is solely responsible for the information contained therein.